Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation
Authors:
- Raphael Bernard-ValnetRBRaphael Bernard-Valnet
- Sylvain PerriotSPSylvain Perriot
- Mathieu CanalesMCMathieu Canales
- Beatrice PizzarottiBPBeatrice Pizzarotti
- Leonardo CaranzanoLCLeonardo Caranzano
- Mayté Castro-JiménezMCMayté Castro-Jiménez
- Jean-Benoit EpineyJEJean-Benoit Epiney
- Sergiu VijialaSVSergiu Vijiala
- Paolo Salvioni-ChiabottiPSPaolo Salvioni-Chiabotti
- Angelica AnichiniAAAngelica Anichini
- Alexander SalernoASAlexander Salerno
- Katia JatonKJKatia Jaton
Open Access
- 1 September 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 8 (5)
Abstract
Objective Coronavirus disease (COVID-19) has been associated with a large variety of neurologic disorders. However, the mechanisms underlying these neurologic complications remain elusive. In this study, we aimed at determining whether neurologic symptoms were caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) direct infection or by either systemic or local proinflammatory mediators. Methods In this cross-sectional study, we checked for SARS-CoV-2 RNA by quantitative reverse transcription PCR, SARS-CoV-2–specific antibodies, and 49 cytokines/chemokines/growth factors (by Luminex) in the CSF +/− sera of a cohort of 22 COVID-19 patients with neurologic presentation and 55 neurologic control patients (inflammatory neurologic disorder [IND], noninflammatory neurologic disorder, and MS). Results We detected anti–SARS-CoV-2 immunoglobulin G in patients with severe COVID-19 with signs of intrathecal synthesis for some of them. Of the 4 categories of tested patients, the CSF of IND exhibited the highest level of cytokines, chemokines, and growth factors. By contrast, patients with COVID-19 did not present overall upregulation of inflammatory mediators in the CSF. However, patients with severe COVID-19 (intensive care unit patients) exhibited higher concentrations of CCL2, CXCL8, and vascular endothelium growth factor A (VEGF-A) in the CSF than patients with a milder form of COVID-19. In addition, we could show that intrathecal CXCL8 synthesis was linked to an elevated albumin ratio and correlated with the increase of peripheral inflammation (serum hepatocyte growth factor [HGF] and CXCL10). Conclusions Our results do not indicate active replication of SARS-CoV-2 in the CSF or signs of massive inflammation in the CSF compartment but highlight a specific impairment of the neurovascular unit linked to intrathecal production of CXCL8.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- SarcoidosisNature Reviews Disease Primers, 2019
- Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier BreakdownInternational Journal of Molecular Sciences, 2019
- Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated CytokinesStem Cell Reports, 2018
- ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmapNucleic Acids Research, 2015
- Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)Infection, 2015
- Sepsis Associated EncephalopathyAdvances in Medicine, 2014
- Advanced glycation end-products disrupt the blood–brain barrier by stimulating the release of transforming growth factor–β by pericytes and vascular endothelial growth factor and matrix metalloproteinase–2 by endothelial cells in vitroNeurobiology of Aging, 2013
- Paraneoplastic Syndromes: An Approach to Diagnosis and TreatmentMayo Clinic Proceedings, 2010
- Multiple organ infection and the pathogenesis of SARSJournal of Experimental Medicine, 2005
- Detection of SARS Coronavirus RNA in the Cerebrospinal Fluid of a Patient with Severe Acute Respiratory SyndromeClinical Chemistry, 2003